Skip to content

CG Oncology CGON Asset turnover

Asset turnover at other companies

Pfizer logo
PfizerPFE
0.3×0.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.5×0.0×
Gilead Sciences logo
Gilead SciencesGILD
0.5×0.0×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
0.3×+0.2×
Tango Therapeutics logo
Tango TherapeuticsTNGX
0.2×0.0×
Summit Therapeutics logo
Summit TherapeuticsSMMT

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Valuation

See full
Market cap$5.39B+206%
Enterprise value$5.36B+212%
P/S1,062.4×-1,596×

Profitability

See full
Operating margin-4,239%-1,872pp
Net margin-3,682.6%-1,601pp
FCF margin-3,163.8%-1,351pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

Based on trailing twelve months.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's asset turnover?
CG Oncology (CGON) reported asset turnover of 0× in Q1 2026.
How has CG Oncology's asset turnover changed year-over-year?
CG Oncology's asset turnover increased by 440.0% year-over-year, from 0× to 0×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.